{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:31:02Z","timestamp":1768548662018,"version":"3.49.0"},"posted":{"date-parts":[[2021,1,20]]},"group-title":"Infectious Diseases (except HIV\/AIDS)","reference-count":57,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2021,1,20]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The rapid and accurate testing of SARS-CoV-2 infection is still crucial to mitigate, and eventually halt, the spread of this disease. Currently, nasopharyngeal swab (NPS) and oropharyngeal swab (OPS) are the recommended standard sampling, yet, with some limitations. Several specimens that are easier to collect are being tested as alternatives to nasal\/throat swabs in nucleic acid assays for SARS-CoV-2 detection. This study aims to critically appraise and compare the clinical performance of RT-PCR tests using oral saliva, deep-throat saliva\/ posterior oropharyngeal saliva (DTS\/POS), sputum, urine, feces, and tears\/conjunctival swab [CS]) against standard specimens (NPS, OPS, or a combination of both).<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>\n                    In this systematic review and meta-analysis, five databases (PubMed, Scopus, Web of Science,\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/ClinicalTrial.gov\">ClinicalTrial.gov<\/jats:ext-link>\n                    and NIPH Clinical Trial) were searched up to the 30\n                    <jats:sup>th<\/jats:sup>\n                    of December 2020. Case-control and cohort studies on the detection of SARS-CoV-2 were included. Methodological quality was assessed through the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS 2).\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Findings<\/jats:title>\n                  <jats:p>We identified 3022 entries, 33 of which (1.1%) met all required criteria and were included for the quantitative data analysis. Saliva presented the higher accuracy, 92.1% (95% CI: 70.0-98.3), with an estimated sensitivity of 83.9% (95% CI: 77.4-88.8) and specificity of 96.4% (95% CI: 89.5-98.8). DTS\/POS samples had an overall accuracy of 79.7% (95% CI: 43.3-95.3), with an estimated sensitivity of 90.1% (95% CI: 83.3-96.9) and specificity of 63.1% (95% CI: 36.8-89.3). Remaining index specimens presented uncertainty given the lack of studies available.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Interpretation<\/jats:title>\n                  <jats:p>Our meta-analysis shows that saliva samples from oral region provide a high sensitivity and specificity, being the best candidate as an alternative specimen to NPS\/OPS for COVID-19 detection, with suitable protocols for swab-free sample collection to be determined and validated in the future. The distinction between oral and extra-oral salivary samples will be crucial since DTS\/POS samples may induce a higher rate of false positives. Urine, feces, tears\/CS and sputum seem unreliable for diagnosis. Saliva testing may increase testing capacity, ultimately promoting the implementation of truly deployable COVID-19 tests, which could either work at the point-of-care (e.g. hospitals, clinics) or outbreak control spots (e.g. schools, airports, and nursing homes).<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Funding<\/jats:title>\n                  <jats:p>Nothing to declare.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Research in context<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Evidence before this study<\/jats:title>\n                    <jats:p>The lack of systematized data on the accuracy performance of alternative specimens for the detection of SARS-CoV-2 (against the standard NPS\/OPS). The ever-growing number of studies available, made this updated systematic review timely and of the utmost importance<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Added value of this study<\/jats:title>\n                    <jats:p>Our meta-analysis shows that saliva samples from the oral region provide a high sensitivity and specificity, being the best candidate as an alternative specimen to NPS\/OPS for COVID-19 detection, with suitable protocols for swab-free sample collection to be determined and validated in the future. The distinction between oral and extra-oral salivary samples will be crucial since DTS\/POS samples may induce a higher rate of false positives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implications of all the available evidence<\/jats:title>\n                    <jats:p>Saliva samples simply taken from the oral cavity are promising alternatives to the currently used nasal\/throat swabs. Saliva specimens can be self-collected, mitigate the discomfort caused by sampling, reduce the transmission risk and increase testing capacity. Therefore, the validation of this alternative specimen will promote the implementation of truly deployable rapid tests for SARS-CoV-2 detection at the point-of-care or outbreak spots.<\/jats:p>\n                  <\/jats:sec>\n                <\/jats:sec>","DOI":"10.1101\/2021.01.19.21250094","type":"posted-content","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T15:10:22Z","timestamp":1611155422000},"source":"Crossref","is-referenced-by-count":13,"title":["Diagnosis of SARS-Cov-2 infection using specimens other than naso- and oropharyngeal swabs: a systematic review and meta-analysis"],"prefix":"10.64898","author":[{"given":"V\u00e2nia M.","family":"Moreira","sequence":"first","affiliation":[]},{"given":"Paulo","family":"Mascarenhas","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2503-260X","authenticated-orcid":false,"given":"Vanessa","family":"Machado","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1019-8263","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Botelho","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0167-4077","authenticated-orcid":false,"given":"Jos\u00e9 Jo\u00e3o","family":"Mendes","sequence":"additional","affiliation":[]},{"given":"Nuno","family":"Taveira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4508-7379","authenticated-orcid":false,"given":"M. Gabriela","family":"Almeida","sequence":"additional","affiliation":[]}],"member":"54368","reference":[{"key":"2021012210351151000_2021.01.19.21250094v1.1","unstructured":"IHME. Covid Projections.."},{"key":"2021012210351151000_2021.01.19.21250094v1.2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.26452\/ijrps.v11iSPL1.2811","article-title":"A review: Coronavirus, its types, and impact of covid-19 on global wealth","volume":"11","year":"2020","journal-title":"Int J Res Pharm Sci"},{"key":"2021012210351151000_2021.01.19.21250094v1.3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00465"},{"key":"2021012210351151000_2021.01.19.21250094v1.4","unstructured":"ECDC. Diagnostic testing and screening for SARS-CoV-2. 2020."},{"key":"2021012210351151000_2021.01.19.21250094v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(05)70348-5"},{"key":"2021012210351151000_2021.01.19.21250094v1.6","doi-asserted-by":"crossref","unstructured":"Ravi N , Cortade DL , Ng E , Wang SX . Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape. 2020.","DOI":"10.1016\/j.bios.2020.112454"},{"key":"2021012210351151000_2021.01.19.21250094v1.7","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/hed.26232","article-title":"Respiratory sampling for severe acute respiratory syndrome coronavirus 2: An Overview","volume":"42","year":"2020","journal-title":"Head Neck"},{"key":"2021012210351151000_2021.01.19.21250094v1.8","doi-asserted-by":"crossref","unstructured":"Sapkota D , S\u00f8land TM , Galtung HK , et al. COVID-19 salivary signature: diagnostic and research opportunities. J Clin Pathol 2020; : jclinpath-2020-206834.","DOI":"10.1136\/jclinpath-2020-206834"},{"key":"2021012210351151000_2021.01.19.21250094v1.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMvcm2010260"},{"key":"2021012210351151000_2021.01.19.21250094v1.10","doi-asserted-by":"publisher","DOI":"10.1177\/0022034520960070"},{"key":"2021012210351151000_2021.01.19.21250094v1.11","doi-asserted-by":"crossref","unstructured":"Barat B , Das S , De Giorgi V , et al. Pooled Saliva Specimens for SARS-CoV-2 Testing. J Clin Microbiol 2020; : 1\u201324.","DOI":"10.1128\/JCM.02486-20"},{"key":"2021012210351151000_2021.01.19.21250094v1.12","doi-asserted-by":"crossref","unstructured":"Braz-Silva PH , Mamana AC , Romano CM , et al. Performance of at-home self-collected saliva and nasal-oropharyngeal swabs in the surveillance of COVID-19. medRxiv 2020; pre-print: 2020.10.23.20218487.","DOI":"10.1101\/2020.10.23.20218487"},{"key":"2021012210351151000_2021.01.19.21250094v1.13","first-page":"1","article-title":"Evaluation of SARS-CoV-2 viral RNA in fecal samples","volume":"17","year":"2020","journal-title":"Virol J"},{"key":"2021012210351151000_2021.01.19.21250094v1.14","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02015-19"},{"key":"2021012210351151000_2021.01.19.21250094v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.05.001"},{"key":"2021012210351151000_2021.01.19.21250094v1.16","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/jmv.25936","article-title":"SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens","volume":"92","year":"2020","journal-title":"J Med Virol"},{"key":"2021012210351151000_2021.01.19.21250094v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104438"},{"key":"2021012210351151000_2021.01.19.21250094v1.18","doi-asserted-by":"crossref","unstructured":"Rao M , Rashid FA , Sabri FSAH , et al. Comparing Nasopharyngeal Swab and Early Morning Saliva for the Identification of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020; : 1\u201327.","DOI":"10.1093\/cid\/ciaa1156"},{"key":"2021012210351151000_2021.01.19.21250094v1.19","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.2147\/IDR.S275152","article-title":"Saliva as an alternative specimen for molecular COVID-19 testing in community settings and population-based screening","volume":"13","year":"2020","journal-title":"Infect Drug Resist"},{"key":"2021012210351151000_2021.01.19.21250094v1.20","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1177\/0022034520940292","article-title":"Oropharyngeal Secretion as Alternative for SARS-CoV-2 Detection","volume":"99","year":"2020","journal-title":"J Dent Res"},{"key":"2021012210351151000_2021.01.19.21250094v1.21","first-page":"1","article-title":"Mass screening of asymptomatic persons for SARS-CoV-2 using saliva","volume":"0","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021012210351151000_2021.01.19.21250094v1.22","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-0187"},{"key":"2021012210351151000_2021.01.19.21250094v1.23","doi-asserted-by":"crossref","unstructured":"Dutescu RM , Banasik P , Schildgen O , Schrage N , Uthoff D. Detection of Coronavirus in Tear Samples of Hospitalized Patients With Confirmed SARS-CoV-2 From Oropharyngeal Swabs. Cornea 2020; Publish Ah: 17\u201320.","DOI":"10.1097\/ICO.0000000000002562"},{"key":"2021012210351151000_2021.01.19.21250094v1.24","first-page":"1","article-title":"Posterior Oropharyngeal Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)","volume":"2","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021012210351151000_2021.01.19.21250094v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.09.018"},{"key":"2021012210351151000_2021.01.19.21250094v1.26","first-page":"3","article-title":"Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Real-Time RT-PCR Tests on Oral Rinses and Saliva Samples","volume":"23","year":"2020","journal-title":"J Mol Diagnostics"},{"key":"2021012210351151000_2021.01.19.21250094v1.27","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1080\/22221751.2020.1775133","article-title":"Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2","volume":"9","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"2021012210351151000_2021.01.19.21250094v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104519"},{"key":"2021012210351151000_2021.01.19.21250094v1.29","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01824-20"},{"key":"2021012210351151000_2021.01.19.21250094v1.30","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-020-0965-2"},{"key":"2021012210351151000_2021.01.19.21250094v1.31","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01946-20"},{"key":"2021012210351151000_2021.01.19.21250094v1.32","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.3390\/jcm9092924","article-title":"Assessing Viral Shedding and Infectivity of Asymptomatic or Mildly Symptomatic Patients with COVID-19 in a Later Phase","volume":"9","year":"2020","journal-title":"J Clin Med"},{"key":"2021012210351151000_2021.01.19.21250094v1.33","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bjid.2020.08.001","article-title":"Saliva is a reliable, non-invasive specimen for SARS-CoV-2 detection","volume":"24","year":"2020","journal-title":"Brazilian J Infect Dis"},{"key":"2021012210351151000_2021.01.19.21250094v1.34","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-020-01548-8"},{"key":"2021012210351151000_2021.01.19.21250094v1.35","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamaophthalmol.2020.1291","article-title":"Characteristics of Ocular Findings of Patients with Coronavirus Disease 2019 (COVID-19) in Hubei Province, China","volume":"138","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"2021012210351151000_2021.01.19.21250094v1.36","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1590\/1806-9282.66.8.1116","article-title":"Comparison of saliva and oro-nasopharyngeal swab sample in the molecular diagnosis of COVID-19","volume":"66","year":"2020","journal-title":"Rev Assoc Med Bras"},{"key":"2021012210351151000_2021.01.19.21250094v1.37","first-page":"9","article-title":"Sensitivity of Nasopharyngeal Swabs and Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2","volume":"27","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021012210351151000_2021.01.19.21250094v1.38","doi-asserted-by":"publisher","DOI":"10.3390\/v12111314"},{"key":"2021012210351151000_2021.01.19.21250094v1.39","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2020.35.e287"},{"key":"2021012210351151000_2021.01.19.21250094v1.40","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/infdis\/jiaa487","article-title":"Prospective Study Comparing Deep Throat Saliva With Other Respiratory Tract Specimens in the Diagnosis of Novel Coronavirus Disease 2019","volume":"222","year":"2020","journal-title":"J Infect Dis"},{"key":"2021012210351151000_2021.01.19.21250094v1.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104567"},{"key":"2021012210351151000_2021.01.19.21250094v1.42","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26258"},{"key":"2021012210351151000_2021.01.19.21250094v1.43","unstructured":"FDA. Emergency Use Authorization issued in August 2020. 2020.."},{"key":"2021012210351151000_2021.01.19.21250094v1.44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"2021012210351151000_2021.01.19.21250094v1.45","unstructured":"Bristol MS of S and CU of. QUADAS2lJ: Background Document. QUADAS2 Backgr Doc 2014; : 8."},{"key":"2021012210351151000_2021.01.19.21250094v1.46","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1411"},{"key":"2021012210351151000_2021.01.19.21250094v1.47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12874-019-0724-x","article-title":"Development of an interactive web-based tool to conduct and interrogate meta-analysis of diagnostic test accuracy studies: MetaDTA","volume":"19","year":"2019","journal-title":"BMC Med Res Methodol"},{"key":"2021012210351151000_2021.01.19.21250094v1.48","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12474"},{"key":"2021012210351151000_2021.01.19.21250094v1.49","doi-asserted-by":"publisher","DOI":"10.1093\/biostatistics\/kxl004"},{"key":"2021012210351151000_2021.01.19.21250094v1.50","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v049.i03"},{"key":"2021012210351151000_2021.01.19.21250094v1.51","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.cmi.2020.07.020","article-title":"Viable SARS-CoV-2 in various specimens from COVID-19 patients","volume":"26","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2021012210351151000_2021.01.19.21250094v1.52","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.3390\/jcm9051491","article-title":"Use of Saliva for Diagnosis and Monitoring the SARS-CoV-2: A General Perspective","volume":"9","year":"2020","journal-title":"J Clin Med"},{"key":"2021012210351151000_2021.01.19.21250094v1.53","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"2021012210351151000_2021.01.19.21250094v1.54","first-page":"1","article-title":"Clinical significance of a high SARS-CoV-2 viral load in the Saliva","volume":"35","year":"2020","journal-title":"J Korean Med Sci"},{"key":"2021012210351151000_2021.01.19.21250094v1.55","unstructured":"Evans RW . Diagnostic testing for SARS-CoV-2 - Interim guidance. 2020."},{"key":"2021012210351151000_2021.01.19.21250094v1.56","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/jmv.25905","article-title":"Positive result of Sarsl\u25a1Cov\u25a12 in faeces and sputum from discharged patients with COVID\u25a119 in Yiwu, China","volume":"92","year":"2020","journal-title":"J Med Virol"},{"key":"2021012210351151000_2021.01.19.21250094v1.57","doi-asserted-by":"crossref","unstructured":"Yu X , Sun S , Shi Y , Wang H , Zhao R , Sheng J . SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression. Crit Care 2020; 24: 170.","DOI":"10.1186\/s13054-020-02893-8"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2021.01.19.21250094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:03:49Z","timestamp":1768485829000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2021.01.19.21250094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,20]]},"references-count":57,"URL":"https:\/\/doi.org\/10.1101\/2021.01.19.21250094","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.3390\/diagnostics11020363","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2021,1,20]]},"subtype":"preprint"}}